Skip to main content
SpringerLink
Log in

Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use

  • Review
  • Tumor-Infiltrating Lymphocytes, Phenotype
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Aebersold P, Hyatt C, Johnson S, Hines K, Korcak L, Sanders M, Lotze M, Topalian S, Yang J, Rosenberg SA (1991) Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response. J Natl Cancer Inst 83: 932

    PubMed  Google Scholar 

  2. Albertini MR, Nicklas JA, Chasternay BF, Hunter TC, Albertini RJ, Clark SS, Hank JA, Sondel PM, (1991) Analysis of the T cell receptor beta and gamma genes from peripheral blood, regional lympho nodes and tumor-infiltrating lymphocyte clones from melanoma patients. Cancer Immunol Immunother 32: 325

    PubMed  Google Scholar 

  3. Alexander J, Connelly R, Edinger M, Tubbs R, Boyett J, Pontes E, Murthy S, Bukowski R, Finke J (1990) Tumor infiltrating lymphocytes from renal cell carcinoma: state of activation, phenotypes and functional analysis. Proc Am Assoc Cancer Res 31: 254

    Google Scholar 

  4. Alexander JP, Kudoh S, Melsop KA, Hamilton TA, Edinger MG, Tubbs RR, Sica D, Tuason L, Klein E, Bukowski RM, Finke JH (1993) T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res 53: 1380

    PubMed  Google Scholar 

  5. Allen C, Hogg N (1987) Elevation of infiltrating mononuclear phagocytes in human colorectal tumors. J Natl Cancer Inst 78: 465

    PubMed  Google Scholar 

  6. Anichini A, Fossati G, Parminani G (1985) Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma. Int J Cancer 35: 683

    PubMed  Google Scholar 

  7. Anichini A, Mazzocchi A, Fossati G, Parmiani G (1989) Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction. J Immunol 142: 3692

    PubMed  Google Scholar 

  8. Applegate KG, Balch CM, Pellis NR (1990) In vitro migration of lymphocytes through collagen matrix: arrested locomotion in tumor-infiltrating lymphocytes. Cancer Res 50: 7153

    PubMed  Google Scholar 

  9. Arienti F, Belli F, Rivoltini L, Gambacorti-Passerini C, Furlan L, Mascheroni L, Prada A, Rizzi M, Marchesi E, Vaglini M, Parmiani G, Cascinelli N (1993) Adoptive immunotherapy of advanced melanoma patients with interleukin 2 (IL2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL2. Cancer Immunol Immunother 36: 315

    PubMed  Google Scholar 

  10. Bilik R, Mor C, Hazaz B, Moroz C (1989) Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer. Cancer Immunol Immunother 28: 143

    PubMed  Google Scholar 

  11. Boon T (1993) Tumor antigens recognized by cytolytic T lymphocytes: present perspective for specific immunotherapy. Int J Cancer 54: 177

    PubMed  Google Scholar 

  12. Broker BM, Tsygankov AY, Muller-Fleckenstein I, Guse AH, Chitaev NA, Biesinger B, Fleckenstein B, Emmrich F (1993) Immortalization of human T cell clones by Herpes virus saimiri. J Immunol 151: 1184

    PubMed  Google Scholar 

  13. Cardi G, Mastrangelo MJ, Berd D (1989) Depletion of T-cells with the CD4+CD45R+ phenotype in lymphocytes that infiltrate subcutaneous metastases of human melanoma. Cancer Res 49: 6562

    PubMed  Google Scholar 

  14. Colombo P, Modesti A, Parmiani G, Forni G (1992) Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T lymphocyte cross talk. Cancer Res 52: 4853

    PubMed  Google Scholar 

  15. Coulie PG, Somville M, Lehmann F, Hainaut P, Brasseur RD, Devos R, Boon T (1992) Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells. Int J Cancer 50: 289

    PubMed  Google Scholar 

  16. Der simonian H, band H, Brenner MB (1991) Increased frequency of T-cell receptor V alpha 12.1 expression on CD8+ T cells: evidence that V alpha participates in shaping the peripheral T cell repertoire. j Exp Med 174: 639–648

    PubMed  Google Scholar 

  17. Dillman RO, Oldham RK, Barth NM, Cohen RJ, Minor DR, Birch R, Yannelli JR, Maleckar JR, Sferruzza A, Arnold J, West WH (1991) Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A National Biotherapy Study Group Trial. Cancer 68: 1

    PubMed  Google Scholar 

  18. Ferradini L, Mackensen A, Genevee C, Bosq J, Duvillard P, Avril MF, Hercend T (1993) Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. J Clin Invest 91: 1183

    PubMed  Google Scholar 

  19. Finke JH, Rayman P, Alexander J, Edinger M, Tubbs RR, Connelly R, Pontes E, Bukowski R (1990) Characterization of the cytolytic activity of CD4+ and CD8− tumor-infiltrating lymphocytes in human renal cell carcinoma. Cancer Res 50: 2363

    PubMed  Google Scholar 

  20. Finke JH, Zea AH, Stanley J, Longo DL, Mizoguchi H, Tubbs RR, Wiltrout RH, O'Shea JJ, Kudoh S, Klein E, Bukowski RM, Ochoa AC (1993) Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res 53: 5613

    PubMed  Google Scholar 

  21. Ioachim HL (1976) The stromal reaction of tumors: an expression of immune surveillance. J Natl Cancer Inst 57: 465

    PubMed  Google Scholar 

  22. Ioannides CG, Friedman RS (1991) Selective usage of TCR V beta in tumor-specific CTL lines isolated from ovarian tumor-associated lymphocytes. Anticancer Res 11: 1921

    Google Scholar 

  23. Ioannides CG, Whiteside TL (1993) T cell recognition of human tumors: implications for molecular immunotherapy of cancer. Clin Immunol Immunopathol 66: 91

    PubMed  Google Scholar 

  24. Itoh K, Platsoucas CD, Balch CM (1988) Autologous tumorspecific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. J Exp Med 168: 1419

    PubMed  Google Scholar 

  25. Jack AS, Boylston AW, Carrel S, Grigor I (1990) Cutaneous T-cell lymphoma cells employ a restricted range of T-cell antigen receptor variable region genes. Am J Pathol 136: 17

    PubMed  Google Scholar 

  26. Jaffee EM, Dranoff G, Cohen LK, Hauda KM, Clift S, Marshall FF, Mulligan RC, Pardoll DM (1993) High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res 53: 2221

    PubMed  Google Scholar 

  27. Kradin RL, Kurnick JT, Lazarus DS, Preffer FI, Dubinett SM, Pinto CE, Gifford J, Davidson E, Grove B, Callahan RJ, Strauss HW (1989) Tumor-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer. Lancet 1: 577

    PubMed  Google Scholar 

  28. Letessier EM, Sacchi M, Johnson JT, Herberman RB, Whiteside TL (1990) The absence of lymphoid suppressor cells in tumor-involved lympho nodes of patients with head and neck cancer. Cell Immunol 130: 446

    PubMed  Google Scholar 

  29. Loeffler CM, Smyth MJ, Longo DL, Kopp WC, Harvey LK, Tribble HR, Tase JE, Urba WJ, Leonard AS, Young HA, Ochoa AC (1992) Immunoregulation in cancer-bearing hosts. Downregulation of gene expression and cytotoxic function in CD8+ T cells. J Immunol 149: 949

    PubMed  Google Scholar 

  30. Mackensen A, Ferradini L, Carcelain G, Triebel F, Faure F, Viel S, Hercend T (1993) Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res 53: 3569

    PubMed  Google Scholar 

  31. Mantovani A (1990) Tumor-associated macrophages. Curr Opin Immunol 2: 689

    Google Scholar 

  32. Mazzocchi A, Belli F, Mascheroni L, Vegetti C, Parmiani G, Anichini A (1994) Frequency of cytotoxic T lymphocyte precursors interacting with the autologous tumor by the T-cell receptor: limiting dilution analysis of specific CTLp in peripheral blood and tumor-invaded lympho nodes of melanoma patients. Int J Cancer (in press)

  33. Miescher S, Whiteside TL, Carrel S, Von Fliedner V (1986) Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 136: 1899

    PubMed  Google Scholar 

  34. Miescher S, Whiteside TL, Moretta L, Von Fliedner V (1987) Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors. J Immunol 138: 4004

    PubMed  Google Scholar 

  35. Miescher S, Stoeck M, Qiao L, Barras C, Barrelet L, Von Fliedner V (1988) Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression. Int J Cancer 42: 659

    PubMed  Google Scholar 

  36. Mizoguchi H, O'Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC (1992) Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258: 1795

    PubMed  Google Scholar 

  37. Morita T, Salmeron MA, Moser RP, Ross MI, Itoh K (1992) Oligoclonal expansion of V beta 8+ cells in interleukin-2-activated T cells residing in subcutaneous metastatic melanoma. Clin Exp Metastasis 10: 69

    PubMed  Google Scholar 

  38. Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin J-L, Vivier E, Anderson P, Kiessling R (1993) Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res 53: 5610

    PubMed  Google Scholar 

  39. Nitta T, Oksenberg JR, Rao NA, Steinman L (1990) Predominant expression of T cell receptor V alpha 7 in tumor-infiltrating lymphocytes of uveal melanoma. Science 249: 672

    PubMed  Google Scholar 

  40. Ogasawara M, Rosenberg SA (1993) Enhanced expression of HLA molecules and stimulation of autologous human tumorinfiltrating lymphocytes following transduction of melanoma cells with gamma interferon genes. Cancer Res 53: 3561

    PubMed  Google Scholar 

  41. Parmiani G, Anichini A, Fossati G (1990) Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy? J Natl Cancer Inst 82: 361

    PubMed  Google Scholar 

  42. Parmiani G, Arienti F, Rivoltini L, Belli F, Cascinelli N (1992) Human tumor-infiltrating lymphocytes in the treatment of cancer. Forum 2: 412

    Google Scholar 

  43. Pitzalis C, Kingsley G, Haskard D, Panayi G (1988) The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion. Eur J Immunol 18: 1397

    PubMed  Google Scholar 

  44. Pretlow TP, Keith EF, Cryar AK, Bartolucci AA, Pitts AM, Pretlow TG, Kimball PM, Bookmaker EA (1987) Eosinophil infiltration of human colon carcinoma as a prognostic indicator. Cancer Res 43: 2997

    Google Scholar 

  45. Rabinowich H, Cohen R, Bruderman I, Steiner Z, Klajman A (1987) Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res 47: 173

    PubMed  Google Scholar 

  46. Rivoltini L, Arienti F, Orazi A, Cefalo G, Gasparini M, Gambacorti-Passerini C, Fossati-Bellani F, Parmiani G (1992) Phenotypic and functional analysis of lymphocytes infiltrating pediatric tumors, with a characterization of the tumor phenotype. Cancer Immunol Immunother 34: 241

    PubMed  Google Scholar 

  47. Rosenberg SA, Packard BS, Aebersold PM, Solomon D, Topalian SL, Toy ST, Simon P, Lotze MT, Yang JC, Seipp CA, Simpson C, Carter C, Bock S, Schwartzentruber D, Wei JP, White DE (1988) Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med 319: 1676

    PubMed  Google Scholar 

  48. Sanders ME, Makgoba MW, Shaw S (1988) Human naive and memory T cells reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today 9: 195

    PubMed  Google Scholar 

  49. Schendel DJ, Gansbacher B (1993) Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment. Cancer Res 53: 4020

    PubMed  Google Scholar 

  50. Sensi ML, Castelli C, Anichini A, Grossberger D, Mazzocchi A, Mortarini R, Parmiani G (1991) Two autologous melanoma-specific and MHC-restricted human T cell clones with identical intra-tumor reactivity do not share the same V alpha and V beta gene families. Melanoma Res 1: 261

    PubMed  Google Scholar 

  51. Sensi M, Salvi S, Castelli C, Maccalli C, Mazzocchi A, Mortarini R, Nicolini G, Herlyn M, Parmiani G, Anichini A (1993) T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clones. J Exp Med 178: 1231

    PubMed  Google Scholar 

  52. Shimizu Y, Iwatsuki S, Herberman RB, Whiteside TL (1990) Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors. Int J Cancer 46: 878

    PubMed  Google Scholar 

  53. Shimizu Y, Iwatsuki S, Herberman RB, Whiteside TL (1991) Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors. Cancer Immunol Immunother 32: 280

    PubMed  Google Scholar 

  54. Shimokawara I, Imamura M, Yamanaka N, Ishii Y, Kikuchi K (1982) Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: an immunoperoxidase study with anti-human T and B cell sera. Cancer 49: 1456

    PubMed  Google Scholar 

  55. Stewart THM, Tsai S-CJ (1993) The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer. Clin Exp Metastasis 11: 295

    PubMed  Google Scholar 

  56. Takagi S, Chen K, Schwarz R, Iwatsuki S, Herberman RB, Whiteside TL (1989) Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin 2. Cancer 63: 102

    PubMed  Google Scholar 

  57. Thor Straten P, Scholler J, Hon-Jansen K, Zenthen J (1994) Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas. Int J Cancer (in press)

  58. Ullman KS, Northrop JP, Verweij CL, Crabtree GR (1993) Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Cancer Res 53: 1

    PubMed  Google Scholar 

  59. Underwood JCE (1974) Lymphoreticular infiltration in human tumors: prognostic and biological implications. A review. Br J Cancer 30: 538

    PubMed  Google Scholar 

  60. Vaccarello L, Kanbour A, Kanbour-Shakir A, Whiteside TL (1993) Tumor-infiltrating lymphocytes from ovarian tumors of low malignant potential. Int J Gynecol Pathol 12: 41

    PubMed  Google Scholar 

  61. Vitolo D, Letessier EM, Johnson JT, Whiteside TL (1992) Immunologic effector cells in head and neck cancer. J Natl Cancer Inst Mono 13: 203

    Google Scholar 

  62. Vitolo D, Zerbe T, Kanbour A, Dahl C, Herberman RB, Whiteside TL (1992) Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int J Cancer 51: 573

    PubMed  Google Scholar 

  63. Vose BM, Moore M (1985) Human tumor-infiltrating lymphocytes: a marker of host response. Semin Hematol 22: 27

    PubMed  Google Scholar 

  64. Weidmann E, Whiteside TL, Giorda T, Herberman RB, Trucco M (1992) The T cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma. Cancer Res 52: 5913

    PubMed  Google Scholar 

  65. Weidmann E, Elder EM, Trucco M, Lotze MT, Whiteside TL (1993) Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma. Int J Cancer 54: 383

    PubMed  Google Scholar 

  66. Weidmann E, Logan TF, Yasumura S, Kirkwood JM, Trucco M, Whiteside TL (1993) Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes. Cancer Res 53: 4745

    PubMed  Google Scholar 

  67. Whiteside TL (1990) Human tumor-infiltrating lymphocytes and their characterization. In: Lotzova E, Herberman RB (eds) Role of interleukin 2 activated killer cells in cancer. CRC Press, Boca Raton, Fla, p 133

    Google Scholar 

  68. Whiteside TL, (1992) Tumor-infiltrating lymphocytes as antitumor effector cells. Biotherapy 5: 47

    PubMed  Google Scholar 

  69. Whiteside TL (1993) Tumor infiltrating lymphocytes in human malignancies. R. G. Landes Company. Austin, Tex

    Google Scholar 

  70. Whiteside TL, Miescher S, Hurlimann J, Von Fliedner V (1986) Separation, phenotyping and limiting-dilution analysis of T-lymphocytes infiltrating human solid tumors. Int J Cancer 37: 803

    PubMed  Google Scholar 

  71. Zocchi MR, Poggi A (1993) Lymphocyte-endothelial cell adhesion molecules at the primary tumor site in human lung and renal cell carcinomas. J Natl Cancer Inst 85: 246

    PubMed  Google Scholar 

  72. Zocchi MR, Ferrarini M, Rugarli C (1990) Selective lysis of the autologous tumor by delta TCS1+gamma/delta+tumor-infiltrating lymphocytes from human lung carcinomas. Eur J Immunol 20: 2685

    PubMed  Google Scholar 

  73. Zocchi MR, Poggi A, Crosti F, Tongiani S, Rugarli C (1992) Signalling in human tumor infiltrating lymphocytes: the CD28 molecule is functional and is physically associated with CD45RO molecule. Eur J Cancer 28A: 749

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pittsburgh Cancer Institute Immunologic Monitoring and Diagnostic Laboratory and Department of Pathology and Otolaryngology, University of Pittsburgh School of Medicine, W1041 Biomedical Science Tower, 211 Lothrop Street, 15213-2582, Pittsburgh, Pa., USA

    Theresa L. Whiteside

  2. Division of Experimental Oncology D, Istituto Nazionale Tumori, Milano, Italy

    Giorgio Parmiani

Authors
  1. Theresa L. Whiteside
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giorgio Parmiani
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Whiteside, T.L., Parmiani, G. Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use. Cancer Immunol Immunother 39, 15–21 (1994). https://doi.org/10.1007/BF01517175

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01517175

Key words

Search

Navigation